(Q42542732)

2 November 2017

QT prolongation and Torsades de Pointes associated with clarithromycin (English)

1 reference

2 November 2017

1 reference

Lee KL

1

1 reference

2 November 2017

Jim MH

series ordinal

2

1 reference

2 November 2017

Tang SC

series ordinal

3

1 reference

2 November 2017

Tai YT

series ordinal

4

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

American Journal of Medicine

2 November 2017

1 reference

2 November 2017

104

1 reference

2 November 2017

395-396

1 reference

2 November 2017

4

1 reference

Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Torsades de pointes induced by erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900059-X

10.1016/S0002-9343(98)00059-X

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference